Lyell Immunopharma EBIT (TTM) Trends

Lyell Immunopharma, Inc. (LYEL)

22.80 -0.66 (-2.81%) USD | NASDAQ | Jan 15, 15:41

View EBIT (TTM) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBIT (TTM) Chart

Start Trial

View Historical Data

Start Trial

View EBIT Definition

Start Trial

EBIT is an acronym for earnings before interest and taxes.

View EBIT (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EBIT (TTM) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Nektar Therapeutics	Upgrade
GT Biopharma, Inc.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade